Hinge Health shares trade near 52-week highs following a 52% surge in Q2 billings, though institutional investors are scaling back positions due to growth sustainability concerns.
Hinge Health delivered exceptional Q2 billings growth of 52% YoY and raised guidance, though the fund is trimming its position due to sustainability concerns.
Hinge Health (HNGE) delivered a strong second quarter, posting a 52% year-over-year increase in billings and raising its forward guidance. Despite this robust performance, Osterweis Opportunity Fund has begun trimming its position, citing concerns regarding the long-term sustainability of current growth rates.
While the fund acknowledges Hinge Health's strong Q2 performance and raised guidance, it believes the company's current growth rates are not sustainable.